Vint Cerf speaks on stage at The 23rd Annual Webby Awards on May 13, 2019 in New York City. Noam Galai/Getty Images for Webby Awards Vint Cerf retired from Google on July 7 after 21 years as the ...

Recent discussion of artificial intelligence in intelligence analysis has consistently framed the technology as a means of accelerating an existing process. The intelligence cycle (collection, ...

On July 4, 2026, Vitalik Buterin published the most consequential Ethereum protocol document in four years: an updated "Lean Ethereum" strawmap that commits the world's second-largest blockchain to ...

Recursion Pharmaceuticals operates as a TechBio company, using its proprietary Recursion OS to automate biological experiments and analyze them with artificial intelligence. The company generates vast ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Gatestone Institute senior fellow Gordon Chang joins 'Mornings with Maria' to discuss new questions surrounding Dr. Anthony Fauci's role in gain-of-function research, China's role in COVID and the ...

Franny "Lady Sophia. I believe functional programming is based on the premise that 'all procedures can be reduced to functions'... but is this self-evident?" Sophia "It is not self-evident. In fact, ...

Senator Rand Paul presents new evidence linking Dr. Anthony Fauci to gain-of-function research in Wuhan, alleging perjury and manipulation of intelligence regarding COVID-19 origins. Gordon Chang and ...

ExtenZe has not been proven to work for erectile dysfunction. Many of ExtenZe's ingredients have no safety or effectiveness studies in humans. The company behind ExtenZe was fined for false ...

Recursion Pharmaceuticals is an AI-focused biotech company looking to revolutionize how we develop drugs. It's arguably long overdue. Despite technological advances, the cost and time required to ...

Recursion Pharmaceuticals' approach to drug discovery could advance the industry. Fiverr is implementing a strategy shift that may help it bounce back from recent headwinds. 10 stocks we like better ...